Posted on 12 January 2010. Tags: Baxter International Inc., David Gauthier-Villars, france, Germany, GlaxoSmithKline PLC, H1N1, Jeanne Whalen, Netherlands, Novartis AG, Roland Jopp, Sanofi-Aventis SA, Spain, Swine Flu, Switzerland, vaccination, World Health Organization
Just months after rushing to order enough swine-flu vaccine to protect their citizens, European governments are canceling orders and trying to sell or give away extra doses as they sit on a glut of the vaccine.
The main reason: European health officials decided that only one shot per person was needed, instead of the two originally planned. Low demand is also to blame. Many Europeans believe the pandemic has turned out to be fairly mild, and don’t see a reason to get vaccinated. Some are also concerned that they will suffer side effects from the shots, despite assurances otherwise from global health officials. Read the full story
VN:F [1.8.7_1070]
Rating: 0.0/10 (0 votes cast)
VN:F [1.8.7_1070]
Posted in Archive, Authors, Business, Featured, Health & Fitness, J.K.
Posted on 20 October 2009. Tags: aches, AstraZeneca unit MedImmune, CDC, Center for Disease Control, cough, CSL Ltd, Dr. Anne Schuchat, fever, flu, GlaxoSmithKline, group A streptococcus, H1N1, hospitalization, incomplete reports, influenza, Novartis AG, Pandemic, Sanofi-Aventis SA, seasonal flu, sore throat, strep throat, Swine Flu, U.S. health officials, United States, Vaccines, virus
By Maggie Fox, Health and Science Editor
WASHINGTON (Reuters) – Half of those hospitalized with the new H1N1 virus are under 25, a clear illustration that the pandemic is affecting the young disproportionately, U.S. health officials said on Tuesday.
They said reports from 27 U.S. states show 53 percent of people sick enough to be hospitalized with H1N1 flu are under the age of 25, with only 7 percent of hospitalizations among people 65 and older. Read the full story
VN:F [1.8.7_1070]
Rating: 0.0/10 (0 votes cast)
VN:F [1.8.7_1070]
Posted in Archive, Health & Fitness, R.T., US Government
Recent Comments